Chemotherapy for patients with colorectal cancer. Potential contributions by the clinical pharmacist: potential contributions by

    Research output: ThesisThesis fully internal (DIV)

    118 Downloads (Pure)

    Abstract

    For over 40 years, 5-fluorouracil, frequently combined with folinic acid, has been the main cytotoxic drug for the treatment of colorectal cancer. In the last decade, however, new cytotoxic agents have been introduced: raltitrexed, irinotecan, oxaliplatin, and oral analogues of 5-fluorouracil, i.e. tegafur in combination with uracil (UFT) and capecitabine. Zie: Summary
    Original languageEnglish
    QualificationDoctor of Philosophy
    Awarding Institution
    • University of Groningen
    Supervisors/Advisors
    • Brouwers, Jacobus, Supervisor
    • Sleijfer, Dirk, Supervisor
    Award date20-May-2005
    Place of PublicationGroningen
    Publisher
    Print ISBNs9036722462
    Publication statusPublished - 2005

    Keywords

    • Proefschriften (vorm)
    • Oncolytica
    • Darmkanker
    • gastro-enterologie

    Cite this